H-Gln-AMC
目录号 : GA22334
H-Gln-AMC是一种荧光底物,通常用于测定谷氨酰环化酶(QC)酶的活性,在pH 8.0时Km值为51 ± 3µM, kcat值为5.4 ± 0.1s-1。
Cas No.:105888-45-7
Sample solution is provided at 25 µL, 10mM.
H-Gln-AMC is a fluorogenic substrate commenly used to measure the activity of glutaminyl cyclase (QC) enzymes with Km value of 51 ± 3µM at pH 8.0 and kcat value of 5.4 ± 0.1s-1[1]. Glutaminyl cyclase (QC) catalyzes the intramolecular cyclization of N-terminal glutaminyl (Gln) and glutamyl (Glu) residues to form pyroglutamic (pGlu) peptides or proteins. Some recent findings suggest that QC can be a potential target against Alzheimer’s disease, Huntington disease and other serious neurodegenerative disease[2].
H-Gln-AMC was used as a fluorescent substrate to detect glutaminyl cyclase (QC) activity in cerebrospinal fluid (CSF) from multiple sclerosis (MS) patients. In CSF, H-Gln-AMC was catalyzed by QC to form pyroglutamyl-AMC, which was subsequently hydrolyzed by pyroglutamyl aminopeptidase to release the fluorescent product AMC. The results show a slight increase in QC activity observed in MS patients, although the difference was not significant[3]. H-Gln-AMC was used as a fluorescent substrate to measure the activity of glutaminyl cyclases (QCs) from Porphyromonas gingivalis (PgQC), Tannerella forsythia (TfQC), and Prevotella intermedia (PiQC). At a concentration of 50μM H-Gln-AMC, the catalytic activity of PgQC, TfQC, and PiQC could be accurately determined based on changes in AMC fluorescence intensity[4].
References:
[1] Schilling S, Hoffmann T, Rosche F, et al. Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity. Biochemistry. 2002 Sep 3;41(35):10849-57.
[2] Szaszkó M, Hajdú I, Flachner B, et al. Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening. Mol Divers. 2017.21:175–186
[3] Gontsarova A, Kaufmann E, Tumani H, et al. Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid. Clin Chim Acta. 2008 Mar;389(1-2):152-9.
[4] Taudte N, Linnert M, Rahfeld J, et al.Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis. J Biol Chem. 2021 Jan-Jun:296:100263.
H-Gln-AMC是一种荧光底物,通常用于测定谷氨酰环化酶(QC)酶的活性,在pH 8.0时Km值为51 ± 3µM, kcat值为5.4 ± 0.1s-1[1]。谷氨酰环化酶(QC)催化n端谷氨酰(Gln)和谷氨酰(Glu)残基的分子内环化,形成热谷氨酸(pGlu)肽或蛋白质。最近的一些研究结果表明,QC可能是治疗阿尔茨海默病、亨廷顿病和其他严重神经退行性疾病的潜在靶点[2]。
H-Gln-AMC可作为荧光底物检测多发性硬化症(MS)患者脑脊液(CSF)中谷氨酰环化酶(QC)活性。在CSF中,H-Gln-AMC经QC催化生成焦谷氨酰-AMC,经焦谷氨酰氨基肽酶水解释放荧光产物AMC。结果显示,MS患者的QC活性略有增加,但差异不显著[3]。以H-Gln-AMC为荧光底物,检测牙龈卟啉单胞菌(PgQC),连翘单宁菌(TfQC)和中间普雷沃菌(PiQC)的QC活性。在50μM H-Gln-AMC浓度下,可以根据AMC荧光强度的变化准确判断PgQC、TfQC和PiQC的催化活性[4]。
H-Gln-AMC 用作 QC 活性测定的底物。
1. 准备50mM Tris-HCl缓冲液,其中含有150mM NaCl,pH为8.0。
2. 在Tris-HCl缓冲液中制备不同浓度的H-Gln-AMC溶液(例如,50µM用于细菌QC催化活性检测)。
3. 在125μL含有H-Gln-AMC溶液加入96孔微孔板,每个孔中加入 0.5U 的吡咯啉氨基肽酶。
4. 将微孔板在30°C下孵育10分钟。
5. 向反应混合物中加入约50nM的QC酶以启动反应。
6. 使用 FluoStar Optima在380/460nm的激发/发射波长下监测荧光强度。
7. 根据在相同测定条件下生成的 AMC 荧光素标准曲线计算QC活性。
该协议仅提供一个指南,应根据您的具体需求进行修改。
References:
[1]Taudte N, Linnert M, Rahfeld J, et al.Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis. J Biol Chem. 2021 Jan-Jun:296:100263.
Cas No. | 105888-45-7 | SDF | |
分子式 | C15H17N3O4 | 分子量 | 303.32 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 3.2968 mL | 16.4842 mL | 32.9685 mL |
5 mM | 0.6594 mL | 3.2968 mL | 6.5937 mL |
10 mM | 0.3297 mL | 1.6484 mL | 3.2968 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet